Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Fresh Tracks Therapeutics Inc V.BBI


Primary Symbol: FRTX

Fresh Tracks Therapeutics, Inc. is not engaged in any business activities. The Company is in the process of dissolution.


GREY:FRTX - Post by User

Comment by Seppelton Nov 30, 2022 5:19pm
211 Views
Post# 35141193

RE:RE:RE:RE:Reply to Seppelt

RE:RE:RE:RE:Reply to Seppelt

By full value I mean prices paid in 2022 which are a lot higher than in 2020 and 2021. For instance, Whitecap buying XTO or TVE buying a private company in Clearwater. May still be good deals based on current oil prices and in the long run but I wouldn't bet on SDE going after PIpe and paying a huge premium to market prices. Riverstone and GMT recently added a large amount of common shares at 85 cents and everyone is posting here about a takeover "tomorrow" at $6 or higher. Definitely not SDE, not these two guys, the Chairman and CEO, if you look at their past deals.
The fact that PIPE is trading close to 52 weeks low is a reaction to Q3 but shares can easily recover from here given some time and strong oil and gas prices. The co is not ready for a takeover, needs a few good quarters showing the management can stick to its guidance, execute and no more negative surprises.

<< Previous
Bullboard Posts
Next >>